SCHEMBL873098

SCHEMBL873098

CCC=CCCCC=CO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
CYP19A1 P11511 4/20 0.45
F7 P08709 3/20 0.45
F3 P13726 3/20 0.45
PPARG P37231 3/20 0.45
OXER1 Q8TDS5 3/20 0.45
PTGS1 P23219 3/20 0.45
PPARA Q07869 3/20 0.45
KMT2A Q03164 2/20 0.45
PPARD Q03181 2/20 0.45
ADORA3 P0DMS8 2/20 0.45
RXRA P19793 2/20 0.45
MAPT P10636 3/20 0.42
NR1I2 O75469 2/20 0.42
PTGS2 P35354 2/20 0.42
FFAR1 O14842 2/20 0.42
CYP3A4 P08684 2/20 0.42
ALOX15 P16050 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TDP1 Q9NUW8 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28038365 1.00 ALDH1A1 (0.45) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL7298871 0.94 ALDH1A1 (0.47) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL6473112 0.92 ALDH1A1 (0.50) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL7287217 0.92 ALDH1A1 (0.50) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL8332555 0.92 ALDH1A1 (0.50) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL7290495 0.88
SCHEMBL4467077 0.85 ALDH1A1 (0.60) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL4557758 0.85 ALDH1A1 (0.60) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL17416905 0.85 ALDH1A1 (0.55) ALDH1A1CYP19A1F7F3PPARG
SCHEMBL17416903 0.85 ALDH1A1 (0.55) ALDH1A1CYP19A1F7F3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302678-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2025-10-02 US claimed
EP-4615941-A2 SUBSTITUTED 1,3-DIOXOLAN-4-ONES AND 1,3-DIOXAN-4-ONES AS FRAGRANCE INGREDIENTS BASF SE (DE) 2025-09-17 EP claimed
US-12350136-B2 Absorbent articles including perfume and cyclodextrins THE PROCTER & GAMBLE COMPANY (US) 2025-07-08 US claimed
US-12338225-B2 2,2,6-trimethyl-4,5-dihydro-3H-oxepine as aroma ingredient BASF SE (DE) 2025-06-24 US claimed
CN-120158100-A Preparation method of high-temperature-resistant corrosion-resistant alloy rubber 上海焦能新材料有限公司 2025-06-17 CN claimed
CN-119924491-A Flavoring composition with balanced taste characteristics 西姆莱斯有限公司 2025-05-06 CN claimed
US-20250092331-A1 COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS BASF SE (DE) 2025-03-20 US claimed
CN-119523908-A Entecavir liposome, preparation and preparation method thereof 齐鲁工业大学(山东省科学院) 2025-02-28 CN claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
US-12187978-B2 Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical BASF SE (DE) 2025-01-07 US claimed
WO-2012162331-A2 COMPOSITIONS COMPRISING AN EFFICIENT PERFUME BLOOM THE PROCTER & GAMBLE COMPANY (US) 2012-11-29 WO claimed
CN-102178207-B Wallace melon essence and preparation method thereof TIANNING FLAVOR & FRAGRANCE JIANGSU CO LTD 2012-06-06 CN claimed
CN-102178207-A Wallace melon essence and preparation method thereof TIANNING FLAVOR & FRAGRANCE JIANGSU CO LTD 2011-09-14 CN claimed
JP-4739231-B2 2011-08-03 JP claimed
CN-101193950-A Fragrance alcohol-releasing polysiloxane DEGUSSA (DE) 2008-06-04 CN claimed
EP-1716159-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS General Electronic Company (US) 2006-11-02 EP claimed
CN-1853603-A Stable composition for hair dye comprising a fragrance TAKASAGO PERFUMERY CO LTD (JP) 2006-11-01 CN claimed
EP-1697386-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES General Electric Company A Corporation of the State of New York (US) 2006-09-06 EP claimed
WO-2005066187-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12338225-B2 2,2,6-trimethyl-4,5-dihydro-3H-oxepine as aroma ingredient DRD4, HTR5A, HTR4 ALDH1A1 503/4885CYP19A1 621/4885F7 2278/4885
US-20250092331-A1 COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS OXER1, MSMO1, IPO7 ALDH1A1 903/4885CYP19A1 493/4885F7 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.